Literaturtipps
Amazon-Bookstore
Marktplatz
aktuelle Angebote/Anfragen
Termine
Messe, Kongreße, Seminare
Produkte
aktuelle Produktinformationen
Unternehmen
über 2600 Firmenprofile
Fachbeiträge
detailierte Fachinformationen
News
aktuelle Verpackungsnachrichten

Liver Transplant Rejection - Pipeline Review: Market Research Hub, Share, Trends, Forecast, H1 2017

11.05.2017 - 17:23 | 1490486


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide “Liver Transplant Rejection Pipeline Review”, H1 2017, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape

Albany, New York, 11 May, 2017: Global Markets Direct''s latest Pharmaceutical and Healthcare disease pipeline guide “Liver Transplant Rejection Pipeline Review”, H1 2017, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape.

Request For Free Sample (at) http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068024

Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability to regenerate or grow, unlike any other organ in the body. Liver transplant replaces an injured or diseased liver with a healthy one. An entire liver or just a section may be transplanted. Following a transplant, the immune system may consider the transplanted liver as foreign and may work against it. Patients may hence develop complications and ultimately reject the new organ. Therefore, immunosuppressive drugs are administered simultaneously. These immunosuppressive drugs prevent the body from either identifying or attacking the foreign organ via various immune responses thus blocking organ rejection and facilitating a successful transplant.

Report Highlights

Global Markets Direct''s Pharmaceutical and Healthcare latest pipeline guide Liver Transplant Rejection Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Liver Transplant Rejection (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II and Preclinical stages are 1, 1, 2 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 1, 1 and 1 molecules, respectively.



Liver Transplant Rejection (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Liver Transplant Rejection (Immunology).
- The pipeline guide reviews pipeline therapeutics for Liver Transplant Rejection (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Liver Transplant Rejection (Immunology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Liver Transplant Rejection (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Liver Transplant Rejection (Immunology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Liver Transplant Rejection (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.

Browse Full Report With TOC (at) http://www.marketresearchhub.com/report/liver-transplant-rejection-pipeline-review-h1-2017-report.html


- Formulate corrective measures for pipeline projects by understanding Liver Transplant Rejection (Immunology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.











Unternehmensinformation / Kurzprofil:

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.


Leseranfragen:
Ajay


ajay.k(at)marketresearchhub.com


PresseKontakt / Agentur:



Contact Details:

90 State Street,

Albany, NY 12207,

United States

Toll Free: 866-997-4948 (US-Canada)

Tel: +1-518-621-2074

Email: press(at)marketresearchhub.com

Website: http://www.marketresearchhub.com/

Follow Us on:

Twitter: https://twitter.com/MktResearchHub

LinkedIn: https://www.linkedin.com/company/market-research-hub

Facebook: https://www.facebook.com/MarketResearchHub/
Anmerkungen:

1490486

Kontakt-Informationen:
Firma: Market Research HUB

Ansprechpartner: Ajay
Stadt: Albany
Telefon: 15186212074

_CSF_KEYWORDS:

liver-transplant-rejection, liver-transplant, liver-transplant-rejection-pipeline,



Diese Meldung wurde bisher 250 mal aufgerufen.

Verlinkung-Tipps:



Direkter Link zu dieser Meldung:




Diese Pressemeldung bookmarken bei...


Tausendreporter BlinkList del.icio.us Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.


Hiermit versichere ich, dass die von mir eingestellte HerstellerNews der Wahrheit entspricht. Sie ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen übernimmt der Eintrager


[ Anfrage per Mail | Fehlerhafte HerstellerNews melden | Druckbare Version | Diese HerstellerNews an einen Freund senden ]

Medium & Heavy Trucks North America (NAFTA) Industry: Share, Trends, Status & Forecast 2017- 2021
Liver Transplant Rejection - Pipeline Review: Market Research Hub, Share, Trends, Forecast, H1 2017
Global Automotive Intelligent Tires Market to grow at a CAGR of 291.23% during the period 2017-2021
Global Welded Blister Packing Market Research Report: Share, Size, Status and Forecast 2022
Global Procure-To-Pay Outsourcing Market Research Report: Share, Size, Status and Forecast to 2022

Alle Meldungen von Market Research HUB RSS Feed

Liver Transplant Rejection - Pipeline Review: Market Research Hub, Share, Trends, Forecast, H1 2017
Global Heat Controllers Industry Research Report: Share, Status, Size, Trends & Forecast to 2021
C-Level Enterprise Data Center Assessment Market Outlook and Opportunities Forecasted for 2017-2023
Global and United States Animal Feed Phytase Market to Gain Impetus during 2017-22, driven by Rising Shortage of Phosphorous
Global Industry Analysis of Polymeric Nanoparticle Market Expected to Grow during 2017-2022




Nach Kategorien:

[ weitere HerstellerNews ][ Archiv ][ RSS-Feed ]





PackTreff ist ein Angebot der LayerMedia. Mehr Infos zum Unternehmen finden Sie hier.
Wenn Sie an Werbung auf PackTreff interessiert sind, so folgen Sie diesemLink
© 2005 - 2011 LayerMedia, Inc. und deren Content-Lieferanten. Alle Rechte vorbehalten.

Startseite
kostenlos registrieren
Firmenprofil eintragen
News veröffentlichen
Produkt eintragen
Jobangebot eintragen
Termin eintragen
Packstoffe & Packmittel
Packhilfsmittel
Verpackungsmaschinen
Ettiketieren & Kennzeichnen
Süßwarenmaschinen
Dienstleistungen
FAQ / Hilfe
Nutzungsbedingungen
Ihre Werbung hier
Feedback
Impressum
kostenlos registrieren
News veröffentlichen
Produkt eintragen
Termin eintragen
Firmenprofil eintragen
Jobangebot eintragen